Need a specific person's email?
Browse Convergent Therapeutics, Inc.'s employee directory (about 40 employees) and reveal verified emails free.
Convergent Therapeutics, Inc.'s most common email format is First.Last@convergentrx.com (ex. John.Doe@convergentrx.com), used for 96% of convergentrx.com addresses. Convergent Therapeutics, Inc. uses 2 email patterns.
| Format | Example | Share of convergentrx.com |
|---|---|---|
| First.Last@convergentrx.comMost common | John.Doe@convergentrx.com | |
| F-Last@convergentrx.com | J-Doe@convergentrx.com |
Browse Convergent Therapeutics, Inc.'s employee directory (about 40 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
Convergent Therapeutics, Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on developing radiopharmaceutical therapies for cancer. It pursues dual-targeted combination strategies that leverage differing biodistributions of targeting agents to deliver higher cumulative doses to tumor cells while avoiding added toxicity. The company has built a platform capable of engaging both validated and novel cancer antigens, including PSMA, to enhance antitumor efficacy. Its work targets cancers where such antigens can be exploited, with a clinical program centered on CONV01-α and related radiopharmaceuticals. In June 2026, the company announced positive Phase 2 data for CONV01-α in lu-PSMA-exposed metastatic castration-resistant prostate cancer at ASCO 2026, indicating promising anti-tumor activity and tolerability.
Most common format
First.Last@convergentrx.com
Example: John.Doe@convergentrx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.